Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas-Reference-Cited by-同舟云学术

Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas

Published:2014-09 Issue:9 Volume:15 Page:
ISSN:1474-760X
Container-title:Genome Biology
language:en
Short-container-title:Genome Biol

Author:

van Thuijl Hinke F,Scheinin Ilari,Sie Daoud,Alentorn Agusti,van Essen Hendrik F,Cordes Martijn,Fleischeuer Ruth,Gijtenbeek Anja M,Beute Guus,van den Brink Wimar A,Meijer Gerrit A,Havenith Miek,Idbaih Ahmed,Hoang-Xuan Khê,Mokhtari Karima,Verhaak Roel GW,van der Valk Paul,van de Wiel Mark A,Heimans Jan J,Aronica Eleonora,Reijneveld Jaap C,Wesseling Pieter,Ylstra Bauke

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13059-014-0471-6.pdf

Reference32 articles.

1. Claus EB, Black PM: Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer. 2006, 106: 1358-1363. 10.1002/cncr.21733.

2. Douw L, Klein M, Fagel SS, van den Heuvel J, Taphoorn MJ, Aaronson NK, Postma TJ, Vandertop WP, Mooij JJ, Boerman RH, Beute GN, Sluimer JD, Slotman BJ, Reijneveld JC, Heimans JJ: Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol. 2009, 8: 810-818. 10.1016/S1474-4422(09)70204-2.

3. Erdem-Eraslan L, Gravendeel LA, de Rooi J, Eilers PH, Idbaih A, Spliet WG, den Dunnen WF, Teepen JL, Wesseling P, Sillevis Smit PA, Kros JM, Gorlia T, van den Bent MJ, French PJ: Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951. J Clin Oncol. 2013, 31: 328-336. 10.1200/JCO.2012.44.1444.

4. van Thuijl HF, Ylstra B, Wurdinger T, van Nieuwenhuizen D, Heimans JJ, Wesseling P, Reijneveld JC: Genetics and pharmacogenomics of diffuse gliomas. Pharmacol Ther. 2013, 137: 78-88. 10.1016/j.pharmthera.2012.09.002.

5. Alentorn A, van Thuijl HF, Marie Y, Alshehhi H, Carpentier C, Boisselier B, Laigle-Donadey F, Mokhtari K, Scheinin I, Wesseling P, Ylstra B, Capelle L, Hoang-Xuan K, Delattre JY, Reijneveld JC, Idbaih A: Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas. Neuro Oncol. 2014, 16: 400-408. 10.1093/neuonc/not227.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients;Cancer Genetics;2023-01

2. MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients;2022-02-15

3. Downregulation of STOX1 is a novel prognostic biomarker for glioma patients;Open Life Sciences;2021-01-01

4. Diffuse low grade gliomas;Česká a slovenská neurologie a neurochirurgie;2020-10-31

5. Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1;Neuro-Oncology Advances;2020-01-01